Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RNA | Common Stock | Options Exercise | $124 | +100 | $1.24* | 100 | Aug 15, 2022 | Direct | F1 | |
transaction | RNA | Common Stock | Sale | -$2.25K | -100 | -100% | $22.47 | 0 | Aug 15, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RNA | Stock Option (Right to Buy) | Options Exercise | $0 | -100 | -0.01% | $0.00 | 1.2M | Aug 15, 2022 | Common Stock | 100 | $1.24 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
F2 | 25% of the shares subject to the option vested on October 7, 2020 and 1/48th of the shares subject to the option will vest monthly thereafter. |